Paulina Bagrowska, Cassandra Wannan, Andrea Polari, Hok Pan Yuen, Paul Amminger, Melissa Kerr, Jessica Spark, Nicky Wallis, Martha Shumway, Cameron Carter, Lisa Dixon, Tara A Niendam, Rachel Loewy, Patrick McGorry, Barnaby Nelson
{"title":"早期精神病治疗过程因素:工作联盟对超高风险青年临床症状和认知偏差的影响","authors":"Paulina Bagrowska, Cassandra Wannan, Andrea Polari, Hok Pan Yuen, Paul Amminger, Melissa Kerr, Jessica Spark, Nicky Wallis, Martha Shumway, Cameron Carter, Lisa Dixon, Tara A Niendam, Rachel Loewy, Patrick McGorry, Barnaby Nelson","doi":"10.1016/j.schres.2025.07.031","DOIUrl":null,"url":null,"abstract":"<p><p>Approximately 25 % of individuals at Ultra High Risk (UHR) transition to a full psychotic disorder. Cognitive biases are thought to play a role in this risk, and improvements in cognitive biases have been associated with better clinical outcomes. Early intervention is crucial, yet no therapeutic approach has proven superior, and treatment adherence remains a challenge. Therapeutic alliance, shown to enhance adherence and clinical outcomes, might also influence depression and cognitive biases, but its role in these domains among UHR patients remains unclear. A total of 202 UHR participants (59.4 % females, mean age 17.4), taking part in the sequential multiple-assignment randomized trial (SMART), completed questionnaires assessing cognitive biases, attenuated psychotic symptoms, quality of life, general and social functioning, depression, and overall psychopathology at baseline, and at 6- and 12-month follow-ups. Additionally, both patients and their corresponding therapists rated working alliance following the 6- and 12-month treatment periods. The results revealed that patient-rated therapeutic alliance significantly predicted improvements in attenuated psychotic symptoms, cognitive biases, general psychopathology, social functioning, and quality of life, with the strongest effects observed when measured 6 months into treatment. The relationship between working alliance and decreases in attenuated psychotic symptoms, as well as between working alliance and reduction in general psychopathology, turned out to be mediated by improvements in cognitive biases. Therapist-rated working alliance did not significantly predict clinical improvements, showing only a minor association with quality of life. Strengthening the therapeutic alliance and prioritizing cognitive bias modification early in interventions for UHR patients may improve treatment outcomes. Further research is needed to validate these findings.</p>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":"284 ","pages":"151-159"},"PeriodicalIF":3.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Therapy process factors in early psychosis: The effect of working alliance on clinical symptoms and cognitive biases in Ultra High Risk young people.\",\"authors\":\"Paulina Bagrowska, Cassandra Wannan, Andrea Polari, Hok Pan Yuen, Paul Amminger, Melissa Kerr, Jessica Spark, Nicky Wallis, Martha Shumway, Cameron Carter, Lisa Dixon, Tara A Niendam, Rachel Loewy, Patrick McGorry, Barnaby Nelson\",\"doi\":\"10.1016/j.schres.2025.07.031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Approximately 25 % of individuals at Ultra High Risk (UHR) transition to a full psychotic disorder. Cognitive biases are thought to play a role in this risk, and improvements in cognitive biases have been associated with better clinical outcomes. Early intervention is crucial, yet no therapeutic approach has proven superior, and treatment adherence remains a challenge. Therapeutic alliance, shown to enhance adherence and clinical outcomes, might also influence depression and cognitive biases, but its role in these domains among UHR patients remains unclear. A total of 202 UHR participants (59.4 % females, mean age 17.4), taking part in the sequential multiple-assignment randomized trial (SMART), completed questionnaires assessing cognitive biases, attenuated psychotic symptoms, quality of life, general and social functioning, depression, and overall psychopathology at baseline, and at 6- and 12-month follow-ups. Additionally, both patients and their corresponding therapists rated working alliance following the 6- and 12-month treatment periods. The results revealed that patient-rated therapeutic alliance significantly predicted improvements in attenuated psychotic symptoms, cognitive biases, general psychopathology, social functioning, and quality of life, with the strongest effects observed when measured 6 months into treatment. The relationship between working alliance and decreases in attenuated psychotic symptoms, as well as between working alliance and reduction in general psychopathology, turned out to be mediated by improvements in cognitive biases. Therapist-rated working alliance did not significantly predict clinical improvements, showing only a minor association with quality of life. Strengthening the therapeutic alliance and prioritizing cognitive bias modification early in interventions for UHR patients may improve treatment outcomes. Further research is needed to validate these findings.</p>\",\"PeriodicalId\":21417,\"journal\":{\"name\":\"Schizophrenia Research\",\"volume\":\"284 \",\"pages\":\"151-159\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Schizophrenia Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.schres.2025.07.031\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.schres.2025.07.031","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Therapy process factors in early psychosis: The effect of working alliance on clinical symptoms and cognitive biases in Ultra High Risk young people.
Approximately 25 % of individuals at Ultra High Risk (UHR) transition to a full psychotic disorder. Cognitive biases are thought to play a role in this risk, and improvements in cognitive biases have been associated with better clinical outcomes. Early intervention is crucial, yet no therapeutic approach has proven superior, and treatment adherence remains a challenge. Therapeutic alliance, shown to enhance adherence and clinical outcomes, might also influence depression and cognitive biases, but its role in these domains among UHR patients remains unclear. A total of 202 UHR participants (59.4 % females, mean age 17.4), taking part in the sequential multiple-assignment randomized trial (SMART), completed questionnaires assessing cognitive biases, attenuated psychotic symptoms, quality of life, general and social functioning, depression, and overall psychopathology at baseline, and at 6- and 12-month follow-ups. Additionally, both patients and their corresponding therapists rated working alliance following the 6- and 12-month treatment periods. The results revealed that patient-rated therapeutic alliance significantly predicted improvements in attenuated psychotic symptoms, cognitive biases, general psychopathology, social functioning, and quality of life, with the strongest effects observed when measured 6 months into treatment. The relationship between working alliance and decreases in attenuated psychotic symptoms, as well as between working alliance and reduction in general psychopathology, turned out to be mediated by improvements in cognitive biases. Therapist-rated working alliance did not significantly predict clinical improvements, showing only a minor association with quality of life. Strengthening the therapeutic alliance and prioritizing cognitive bias modification early in interventions for UHR patients may improve treatment outcomes. Further research is needed to validate these findings.
期刊介绍:
As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!
Schizophrenia Research''s time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.
The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.